047Scherbakov_Omez.

qxd

11.02.2013

16:29

Page 47

..
,

. 
: , 2
.
. 

, , , 
, .
: , ,
, , .




/ 
.





(). 1910 . .
: [1].

,

. 
52000


8% 
,
29,4%, 
16,2%, 
1,1%.

45,3% . 
, 
: 
, pol_ochka@rambler.ru


26,7% [2].

. 


, : 
( , ,
, ).
, 
, , 

: , 
.

. 
, 
, 
,

[3]. 


, 

.

,
: 

4.2012 47

047Scherbakov_Omez.qxd

11.02.2013

16:29

Page 48

,
, ;
2 , 

, 

;
(),


.

, 


(). , 

, 
, . 
2 

, 


[4]. , 

2
, 

[5].

,
. 

2 [6].
2 


.



,

.



(, , ,

48 4.2012

, 
.),


. , 


, . 

1974 . 1975 .

, 1979 . 
.




+/+
. 
, 
,
,
,
SH
+/+ 

, 
, 
.
, 

,

[7].

: ,
, .
, 

, , 
.

( <3,0).





.

047Scherbakov_Omez.qxd

11.02.2013

16:29

Page 49

, 

, 
,
,

. 1988 . 



[8].

. 


. ,
, 
. 

, 
.

,



. 1983 .
, 


Helicobacter pylori
(H. pylori) [9].



, .
1988 .
D.Y. Graham . :
, H. pylori
[1].

, H. pylori,

.
H. pylori

[10]. 

,
, 

,
H. pylori 
.


.


.

,
. 
H. pylori,

,

. ,
, 



( ).
, 
H. pylori,
[8].
,
(
) 
, 

H. pylori. 
,

[1113].

,
,
.

, 
, 
, 
( 
),
(, 
), 

4.2012 49

047Scherbakov_Omez.qxd

11.02.2013

16:29

Page 50

, 
, 

. 



. 
,

(),
.



. ,
H. pylori, 
, 
.

, 


.


.

.

, 
, 
, 

,
5055% ( 
). 
0,53,5 ;
95%.
0,51 (
) 3 (
). 

, 
(7280%)
(1823%).
20 
1 , 
2 24 .

50 4.2012

.


35
. 

[7]. 

;
.

()

, 


[1416]. 

. ,

, 

, 

.

,
() (
), 10 . 


.


2
. 

[17]. 


. 

, 

, ,


.

047Scherbakov_Omez.qxd

11.02.2013

16:29

Page 51




.
,


, . 

, 6
90% 

, 
, 1
.
,


[7].

(, 
)
( 20 , 30 ,
40 , 20
20 ), 12
2030 . 

68 . 
,


12 .

.
450 

,


(, 
, , , ,
R .).
,

, 

. 


().



( ) [18]. 


.

,



12 .

, ..
: 
20 
[19]. 


[20].



. 
, , 
,
,
, .


[21].

. 


. 

, .


, Green 
1977 . 
[22]. 
,
, 



4.2012 51

047Scherbakov_Omez.qxd

11.02.2013

16:29

Page 52



. 

.

,

. 
,



[21, 22]. 

,
, 

, 
. 

,
[23,
24].

, 
. 
, 
,

,
.

. 

, 
, 

. 

72
.

, [25].


.

7  


. 
, 

[26]. , 


, :
, 
[2732].
,

. 

.
,

, 


, , ,

, 
[33].


www.atmosphere$ph.ru

Proton Pump Inhibitors: Practical Approaches

P.L. Scherbakov
Chronic diseases of the upper digestive tract are accompanied by excess production of stomach acid. Three groups
of drugs are used to regulate stomach acid production: antacids, 2blockers, and proton pump inhibitors. Proton
pump inhibitors, such as omeprazole, are the most effective drugs. Omeprazole is well tolerated and successfully
used for the treatment of gastric and duodenal ulcers, gastroesophageal reflux disease, NSAID gastropathy, and
helicobacteriosis.
Key words: gastric ulcer, duodenal ulcer, gastroesophageal reflux disease, proton pump inhibitors, omeprazole.

52 4.2012